These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 17382282

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.
    Groeneveld PW, Lieu TA, Fendrick AM, Hurley LB, Ackerson LM, Levin TR, Allison JE.
    Am J Gastroenterol; 2001 Feb; 96(2):338-47. PubMed ID: 11232673
    [Abstract] [Full Text] [Related]

  • 3. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects.
    Sonnenberg A.
    Am J Gastroenterol; 1996 Sep; 91(9):1773-7. PubMed ID: 8792696
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment?
    Pohl H, Finlayson SR, Sonnenberg A, Robertson DJ.
    Aliment Pharmacol Ther; 2005 Sep 15; 22(6):529-37. PubMed ID: 16167969
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of Helicobacter pylori "test and treat" for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: a Markov model analysis.
    You JH, Wong PL, Wu JC.
    Scand J Gastroenterol; 2006 Jan 15; 41(1):21-9. PubMed ID: 16373272
    [Abstract] [Full Text] [Related]

  • 8. Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis.
    Fendrick AM, Chernew ME, Hirth RA, Bloom BS.
    Yale J Biol Med; 1996 Jan 15; 69(2):187-95. PubMed ID: 9112750
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of and satisfaction with a Helicobacter pylori "test and treat" strategy compared with prompt endoscopy in young Asians with dyspepsia.
    Mahadeva S, Chia YC, Vinothini A, Mohazmi M, Goh KL.
    Gut; 2008 Sep 15; 57(9):1214-20. PubMed ID: 18441005
    [Abstract] [Full Text] [Related]

  • 10. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ, Liu CF, Crump C, Brousal A.
    Am J Gastroenterol; 2003 Sep 15; 98(9):1952-62. PubMed ID: 14499771
    [Abstract] [Full Text] [Related]

  • 11. Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States.
    Ladabaum U, Fendrick AM, Glidden D, Scheiman JM.
    Am J Gastroenterol; 2002 Dec 15; 97(12):3007-14. PubMed ID: 12492183
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of eradication of Helicobacter pylori in gastric cancer survivors after endoscopic resection of early gastric cancer.
    Shin DW, Yun YH, Choi IJ, Koh E, Park SM.
    Helicobacter; 2009 Dec 15; 14(6):536-44. PubMed ID: 19889071
    [Abstract] [Full Text] [Related]

  • 13. Helicobacter pylori and non-malignant diseases.
    Kupcinskas L, Malfertheiner P.
    Helicobacter; 2005 Dec 15; 10 Suppl 1():26-33. PubMed ID: 16178968
    [Abstract] [Full Text] [Related]

  • 14. Role of Helicobacter pylori in gastrointestinal disease: implications for primary care of a revolution in management of dyspepsia.
    Delaney BC.
    Br J Gen Pract; 1995 Sep 15; 45(398):489-94. PubMed ID: 7546874
    [Abstract] [Full Text] [Related]

  • 15. [Economic evaluation of H. pylori eradication].
    Ikeda S.
    Nihon Rinsho; 2003 Jan 15; 61(1):146-51. PubMed ID: 12607332
    [Abstract] [Full Text] [Related]

  • 16. Helicobacter pylori and non-malignant diseases.
    Rokkas T, Simsek I, Ladas S.
    Helicobacter; 2007 Oct 15; 12 Suppl 1():20-2. PubMed ID: 17727456
    [Abstract] [Full Text] [Related]

  • 17. Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective?
    Breuer T, Graham DY.
    Am J Gastroenterol; 1999 Mar 15; 94(3):725-9. PubMed ID: 10086658
    [Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.
    Lee YC, Lin JT, Wu HM, Liu TY, Yen MF, Chiu HM, Wang HP, Wu MS, Hsiu-Hsi Chen T.
    Cancer Epidemiol Biomarkers Prev; 2007 May 15; 16(5):875-85. PubMed ID: 17507609
    [Abstract] [Full Text] [Related]

  • 19. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
    Mason JM, Moayyedi P, Young PJ, Duffett S, Crocombe W, Drummond MF, Axon AT.
    Int J Technol Assess Health Care; 1999 May 15; 15(4):649-60. PubMed ID: 10645106
    [Abstract] [Full Text] [Related]

  • 20. A cost analysis of a Helicobacter pylori eradication strategy in a large health maintenance organization.
    Levin TR, Schmittdiel JA, Henning JM, Kunz K, Henke CJ, Colby CJ, Selby JV.
    Am J Gastroenterol; 1998 May 15; 93(5):743-7. PubMed ID: 9625120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.